Ventas, Inc. 8-K Filing

Ticker: VTR · Form: 8-K · Filed: Nov 17, 2025 · CIK: 740260

Ventas, Inc. 8-K Filing Summary
FieldDetail
CompanyVentas, Inc. (VTR)
Form Type8-K
Filed DateNov 17, 2025
Pages2
Reading Time2 min
Key Dollar Amounts$0.25
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a 8-K filing submitted by Ventas, Inc. (ticker: VTR) to the SEC on Nov 17, 2025.

What are the key financial figures in this filing?

Key dollar amounts include: $0.25 (nge on which registered Common stock, $0.25 par value VTR New York Stock Exchange).

How long is this filing?

Ventas, Inc.'s 8-K filing is 2 pages with approximately 520 words. Estimated reading time is 2 minutes.

Where can I view the full 8-K filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-11-17 16:05:36

Key Financial Figures

  • $0.25 — nge on which registered Common stock, $0.25 par value VTR New York Stock Exchange

Filing Documents

02 Departure of Directors or Certain

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 17, 2025, Ventas, Inc. (the "Company") announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc., is expected to retire effective as of May 1, 2026 (the "Effective Date"). Mr. Bulgarelli will remain in his role through the Effective Date. Mr. Bulgarelli's advance notice of his retirement allows lead time for the Company to conduct a comprehensive search for his replacement and for Mr. Bulgarelli to assist with the orderly transition of duties to his successor. A copy of the press release announcing Mr. Bulgarelli's retirement is attached as Exhibit 99.1 and incorporated herein by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release issued by the Company on November 17 , 2025 104 Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VENTAS, INC. Date: November 17, 2025 By: /s/ Carey S. Roberts Carey S. Roberts Executive Vice President, General Counsel, Ethics and Compliance Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.